Losartan Potassium Tablet, Film Coated
Product Images NDC 68071-5041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-5041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5041 9)

Pdp (68071 5041 9)
This is a description of Losartan Potassium 25mg tablets manufactured by NuCare Pharmaceuticals, Inc. It contains 90 tablets with the NDC number 65862-201-90 and the expiration date of 00-00. The LOT# is 000000 and the serial number is 00000000002. The GTIN is 00368071504194. The label warns to keep out of reach of children and to store at a controlled temperature of 59-86°F. Rx only 1-800-FDA-1088 should be contacted for any issues.*
FDA Label Image

Figure1 (Losartan Fig1)

Figure1 (Losartan Fig1)
The text appears to show a comparison between the medications Atenolol and Losartan Potassium, and includes a statistic for "Adjusted Risk Reduction" with a corresponding p-value. The rest of the text contains numeric values that may relate to a study timeline or duration.*
FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

Figure 3 (Losartan Fig3)
The text provided is related to figures showing primary endpoint events within demographic subgroups. The figures show the results of a study, but due to the poor quality of the text, it's not possible to interpret it.*
FDA Label Image

Figure-4 (Losartan Fig4)

Figure-4 (Losartan Fig4)
This text provides information on the percentage of patients who experienced an event for Losttan Potassium and Placebo. The event rate for Losttan Potassium was 60%, while it was 40% for Placebo, resulting in a risk reduction of 16.1%. The text also indicates a statistical significance of p=0.022.*
FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.